Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Edible Garden AG, a Nasdaq-listed leader in controlled environment agriculture, announced a strategic partnership with Square Roots to develop a new generation of clean-label, functional ready-to-drink beverages. Combining Square Roots' expertise in plant science with Edible Garden's advanced Farm-to-Formula® platform and aseptic manufacturing, the…
Biogen and Eisai announced US availability of LEQEMBI IQLIK®, a subcutaneous autoinjector for initiation and maintenance therapy of early Alzheimer's disease, offering a more convenient and flexible alternative to intravenous infusion. The treatment, supported by robust clinical trial data demonstrating slowed disease progression and significant co…
Clearmind Medicine Inc., a clinical-stage biotech focused on psychedelic-derived neuroplastogens, announced the U.S. publication of a patent application covering a novel combination of MDMA and N-acylethanolamines such as PEA, aimed at treating PTSD, anxiety, and eating disorders. This comes alongside the FDA's newly finalized guidance for clinical…
Merlin, Inc., an aerospace and defense technology company specializing in autonomous flight systems, has received the Part 146 Aircraft Design Organization certificate from the Civil Aviation Authority of New Zealand. This certification authorizes Merlin's engineers to approve certain aircraft design changes internally, reducing reliance on externa…
Liminatus Pharma has engaged Synex Consulting Ltd. as the contract research organization to conduct Phase 1/2a clinical trials of its investigational CD19xCD22 bivalent CAR-T therapy (IBC101) targeting relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The engagement supports clinical trial execution in South Korea following regulatory a…
TryHard Holdings Limited successfully executed a record-setting 4,000-drone light show at the 10th anniversary SBI Fireworks Festival in Osaka, Japan. The performance marked the first collaboration under a strategic partnership with SBI MUSIC CIRCUS, EHang Egret Media Technology, and SKYTEK, integrating drone technology with traditional fireworks a…
ZJK Industrial Co., Ltd., a precision parts manufacturer listed on NASDAQ, announced securing large-volume purchase orders for AI infrastructure components from major customers. The company is expanding production capacity and focusing on AI liquid cooling solutions to meet growing demand driven by next-generation AI chip power requirements. Manage…
Abundia Global Impact Group, Inc., a low-carbon energy company converting biomass and plastics waste into fuels, announces authorization of a $5 million stock buyback program representing approximately 12% of outstanding shares. This move aims to prioritize shareholder value, support listing compliance, and reflects management's belief that the sto…
NANO Nuclear Energy Inc. announced a strategic commercial framework agreement with Tillman Global Holdings to provide advanced nuclear reactor technology to power Tillman's planned gigawatt-scale AI industrial zones across the U.S. The companies aim to deploy 2 GW or more of advanced nuclear capacity by the mid-2030s and 6 GW or more by 2040, utili…
TeraWulf Inc. announced that the Kentucky Public Service Commission has approved a Retail Electric Service Agreement supporting up to 482 MW of electric service for its Justified Data Campus in Kentucky. This approval secures substantial power capacity at a repurposed industrial site, ensuring project costs and risks are borne by TeraWulf, protecti…
Datacentrex, Inc. has secured colocation capacity for deployment of more than 500 prepaid ElphaPex DG2 Scrypt ASIC miners, expected to be energized within 30 days. This expansion will increase the company's aggregate hashrate by approximately 21%, improving fleet energy efficiency without additional capital expenditure. The deployment aligns with i…
TTEC Holdings, Inc. has been awarded the Gold award in the 2026 Brandon Hall Group HCM Excellence Awards for their RealSkill AI-Driven Workforce Readiness program. The program uses AI-powered simulations and personalized coaching to help employees practice and improve customer interaction skills. This recognition highlights TTEC's leadership in app…
Erasca, Inc. announced that the FDA has granted Fast Track Designation to its investigational drug ERAS-0015 for metastatic pancreatic adenocarcinoma. The designation is based on promising Phase 1 data demonstrating clinical activity and tolerability in multiple tumor types, including pancreatic and lung cancers. The company plans three potentially…
AEON Biopharma, listed on NYSE American as AEON, has named Paul Lee, M.D., Ph.D., former Deputy Director at the FDA's Office of Neuroscience, as acting Chief Regulatory Officer. Dr. Lee, who has been advising AEON on regulatory strategy via Clintrex Research LLC, will now lead the company’s interactions with the FDA and oversee the regulatory roadm…
Bionano Genomics, a Nasdaq-listed biotechnology company specializing in genome analysis solutions, announced that its management will present and hold one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The presentation will showcase the company’s advancements in optical genome mapping technolo…
Humacyte, Inc. announced that following favorable discussions with the FDA, it intends to file a supplemental Biologics License Application (BLA) in November 2026 to expand approval of its acellular tissue engineered vessel (ATEV) for dialysis access. This follows FDA approval of ATEV for vascular trauma in 2024. The application will be supported b…
Elicio Therapeutics announced its management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference to discuss its development of next-generation immunotherapies for KRAS-driven cancers. The company focuses on off-the-shelf immunotherapy candidates, aiming to improve treatment for solid tumors driven by KRAS, B…
ASML Holding N.V., a global leader in semiconductor equipment manufacturing, has disclosed recent transactions under its ongoing share buyback program announced in January 2026. Over five consecutive days in August, ASML repurchased a total of approximately 252,684 shares at weighted average prices ranging from €1,506.98 to €1,618.13 per share. The…
Evolution Metals & Technologies Corp. (Nasdaq: EMAT), a U.S.-based critical materials and manufacturing company, announced its preliminary inclusion in FTSE Russell's Russell 3000® and Russell 2000® indexes, effective September 21, 2026, pending final review. This inclusion is anticipated to increase the company's visibility among institutional and…
Rhythm Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare has approved IMCIVREE® (setmelanotide) to treat patients with acquired hypothalamic obesity (HO), a rare disease characterized by significant weight gain due to hypothalamic injury. Supported by positive Phase 3 trial data, this marks IMCIVREE as the first approved…
Morocco's grain office ONICL has announced the resumption of soft wheat imports beginning September 16, with import subsidies in place until December 31. The measure follows a pause in purchases in June to prioritize a domestic harvest that recovered in 2026, and the subsidy will cover the difference between a 270-dirham-per-quintal reference price…
Halozyme is no longer a small-platform play. With guidance pointing to $1.71-$1.81B in 2026 revenue, royalty streams topping $1B, robust free cash flow, and an opportunistic $300M acquisition, the company looks positioned to compound value into 2027. Technicals are hot, so the trade recommends a disciplined long entry with a clear stop and a pragma…
Sika manufactures specialty chemicals and systems that increase the effective materials content per construction project. With steady end-market fundamentals, price and mix levers, and a track record of share gains, Sika sets up as a compounder inside a construction cycle. This trade idea outlines an actionable long entry, stop, and target, framed …
Walmart plunged after a weak comp-sales print on 08/20/2026, but a deeper look at valuation and margin pressure argues the sell-off did not fully correct for slowing growth. This trade idea recommends a tactical short with a mid-term horizon, precise entry, stop and target, and clear risk controls.
BriaCell Therapeutics Corp. announced progress in its personalized off-the-shelf immunotherapy vaccine candidate Bria-MEL+ for melanoma, highlighting the achievement of a key genetic engineering milestone advancing the program toward clinical trials. This vaccine leverages patient-specific HLA matching without individualized manufacturing, aiming t…
